{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:35:39Z","timestamp":1789850139037,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jmb.2006.12.004","type":"journal-article","created":{"date-parts":[[2006,12,16]],"date-time":"2006-12-16T12:14:37Z","timestamp":1166271277000},"page":"618-638","source":"Crossref","is-referenced-by-count":76,"title":["Structural and Thermodynamic Study on Aldose Reductase: Nitro-substituted Inhibitors with Strong Enthalpic Binding Contribution"],"prefix":"10.1016","volume":"368","author":[{"given":"Holger","family":"Steuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2006.12.004_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/13543776.12.5.621","article-title":"Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications","volume":"12","author":"Miyamoto","year":"2002","journal-title":"Expert. Opin. Ther. Patents"},{"key":"10.1016\/j.jmb.2006.12.004_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmb.2006.12.004_bib3","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/jm0306273","article-title":"Diabetes mellitus: pathogenesis and treatment strategies","volume":"47","author":"Skyler","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2006.12.004_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/cr0204653","article-title":"Chemistry and biochemistry of type 2 diabetes","volume":"104","author":"Ross","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmb.2006.12.004_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/diab.44.12.1355","article-title":"Clinical trials of diabetic neuropathy: past, present and future","volume":"44","author":"Pfeifer","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2006.12.004_bib7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2174\/0929867033457377","article-title":"Recent studies of aldose reductase enzyme inhibition for diabetic complications","volume":"10","author":"Suzen","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(24)01347-4","article-title":"Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications","volume":"50","author":"Yabe-Nishimura","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jmb.2006.12.004_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2006.12.004_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.jmb.2006.12.004_bib11","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/diabetes.53.7.1851","article-title":"Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy. Interactions with aldose reductase","volume":"53","author":"Price","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2006.12.004_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2337\/diabetes.50.4.851","article-title":"Diabetes accelerates smoth muscle accumulation in lesions of atherosclerosis. Lack of direct growth-promoting effects of high glucose levels","volume":"50","author":"Suzuki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2006.12.004_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s001250051646","article-title":"Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity","volume":"44","author":"Nakamura","year":"2001","journal-title":"Diabetologica"},{"key":"10.1016\/j.jmb.2006.12.004_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diabres.2006.02.010","article-title":"The role of polyol pathway in high glucose-induced endothelial cell damages","volume":"73","author":"Oyama","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jmb.2006.12.004_bib15","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1159\/000080684","article-title":"Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression","volume":"98","author":"Dan","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.jmb.2006.12.004_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2003.08.017","article-title":"Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease","volume":"419","author":"Jerums","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmb.2006.12.004_bib17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.53.3.580","article-title":"Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group","volume":"53","author":"Greene","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2006.12.004_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7","article-title":"Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches","volume":"19","author":"Constantino","year":"1999","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmb.2006.12.004_bib19","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1093\/brain\/124.12.2448","article-title":"Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor","volume":"124","author":"Yagihashi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jmb.2006.12.004_bib20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/jm034065z","article-title":"A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one","volume":"46","author":"Mylari","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1085-9489.2006.00085.x","article-title":"Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients","volume":"11","author":"Baba","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jmb.2006.12.004_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7","article-title":"Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches","volume":"19","author":"Constantino","year":"1999","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmb.2006.12.004_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/prot.20001","article-title":"Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors","volume":"55","author":"El-Kabbani","year":"2004","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2006.12.004_bib24","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/jm0492094","article-title":"Discovery of 3- [(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (Lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications","volume":"48","author":"Van Zandt","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/prot.20015","article-title":"Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66\u00a0\u00c5","volume":"55","author":"Howard","year":"2004","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2006.12.004_bib26","first-page":"19","article-title":"Structural features of the aldose reductase and aldehyde reductase inhibitor binding sites","volume":"4","author":"El-Kabbani","year":"1998","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jmb.2006.12.004_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0006-2952(90)90490-C","article-title":"Inhibition of aldehyde reductase by aldose reductase inhibitors","volume":"40","author":"Sato","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmb.2006.12.004_bib28","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1016\/j.bmc.2004.07.062","article-title":"Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications","volume":"12","author":"Van Zandt","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exger.2003.08.009","article-title":"Possible role of alteration of aldehyde's scavenger enzymes during aging","volume":"39","author":"Davydov","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jmb.2006.12.004_bib30","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1021\/jm990502r","article-title":"A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2\u2032, 5\u2032-dioxospiro [chroman-4,4(-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography","volume":"43","author":"Oka","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jmb.2005.10.067","article-title":"High resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group","volume":"356","author":"Steuber","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.12.004_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<218::AID-PROT7>3.0.CO;2-E","article-title":"Modelling the catalytic reaction in human aldose reductase","volume":"37","author":"Varnai","year":"1999","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2006.12.004_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1051\/jp4:20001001","article-title":"Model of the catalytic mechanism of human aldose reductase based on quantum chemical calculations","volume":"10","author":"Cachau","year":"2000","journal-title":"J. Phys. IV France"},{"key":"10.1016\/j.jmb.2006.12.004_bib34","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/jm000483h","article-title":"Discovery of novel aldose reductase inhibitors using a protein-structure-based approach: 3D-database search followed by design and synthesis","volume":"44","author":"Iwata","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib35","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0968-0896(01)00410-2","article-title":"Discovery of new inhibitors of aldose reductase from molecular docking and database screening","volume":"10","author":"Rastelli","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib36","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1021\/jm049756p","article-title":"Soft docking and multiple receptor conformations in virtual screening","volume":"47","author":"Ferrari","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/prot.20057","article-title":"Virtual screening for inhibitors of human aldose reductase","volume":"55","author":"Kr\u00e4mer","year":"2004","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2006.12.004_bib38","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1002\/anie.200500592","article-title":"Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: a critical view of the relevance of in vitro metalloenzyme assays","volume":"44","author":"Schiffmann","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jmb.2006.12.004_bib39","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/anie.200462643","article-title":"An old target revisited: two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors","volume":"44","author":"Specker","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jmb.2006.12.004_bib40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries","volume":"432","author":"Shoichet","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2006.12.004_bib41","first-page":"513","article-title":"The devil is still in the details\u2013driving early drug discovery forward with biophysical experimental methods","volume":"8","author":"Lundqvist","year":"2005","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.jmb.2006.12.004_bib42","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1107\/S0907444904011370","article-title":"The crystallographic structure of the aldose reductase-IDD 552 complex shows direct proton donation from tyrosine 48","volume":"60","author":"Ruiz","year":"2004","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2006.12.004_bib43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1107\/S0907444900002341","article-title":"The structure of human aldose reductase bound to the inhibitor IDD 384","volume":"56","author":"Calderone","year":"2000","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2006.12.004_bib44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A computational procedure for determining energetically favourable binding sites on biologically important macromolecules","volume":"28","author":"Goodford","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib45","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1073\/pnas.1432955100","article-title":"Electrostatic complementarity in an aldose reductase complex from ultra-high-resolution crystallography and first-principles calculations","volume":"100","author":"Muzet","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2006.12.004_bib46","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00018-003-3405-0","article-title":"Ultra-high-resolution X-ray structure of proteins","volume":"61","author":"Lecomte","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2006.12.004_bib47","doi-asserted-by":"crossref","first-page":"16789","DOI":"10.1073\/pnas.0407607101","article-title":"Halogen bonds in biological molecules","volume":"101","author":"Auffinger","year":"2004","journal-title":"Proc. Natl Acad. Sci.USA"},{"key":"10.1016\/j.jmb.2006.12.004_bib48","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0006-3495(96)79403-1","article-title":"Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry","volume":"71","author":"Baker","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmb.2006.12.004_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1097-0134(2000)41:4+<93::AID-PROT90>3.0.CO;2-0","article-title":"Binding of small organic molecules to macromolecular targets: evaluation of conformational entropy changes","volume":"4","author":"D'Aquino","year":"2000","journal-title":"Proteins: Struct. Funct. Genet. (suppl.)"},{"key":"10.1016\/j.jmb.2006.12.004_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.264.5159.670","article-title":"The entropic cost of bound water in crystals and biomolecules","volume":"264","author":"Dunitz","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jmb.2006.12.004_bib51","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1021\/ja0601639","article-title":"Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase","volume":"128","author":"Yin","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2006.12.004_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrd1129","article-title":"Implications of protein flexibility for drug discovery","volume":"2","author":"Teague","year":"2003","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2006.12.004_bib53","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/cbic.200500010","article-title":"Probing the binding entropy of ligand-protein interactions by NMR","volume":"6","author":"Homans","year":"2005","journal-title":"ChemBioChem."},{"key":"10.1016\/j.jmb.2006.12.004_bib54","doi-asserted-by":"crossref","first-page":"16167","DOI":"10.1021\/ja054519c","article-title":"Enthalpy-entropy compensation is not a general feature of weak association","volume":"127","author":"Ford","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2006.12.004_bib55","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/anie.200390319","article-title":"Interactions with aromatic rings in chemical and biological recognition","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmb.2006.12.004_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00646936","article-title":"Group contributionsto the thermodynamic properties of non-ionic solutes in dilute aqueous solution","volume":"10","author":"Cabani","year":"1981","journal-title":"J. Sol. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib57","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1021\/ja0527525","article-title":"Van der Waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water","volume":"127","author":"Barratt","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2006.12.004_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature04162","article-title":"Interfaces and the driving force of hydrophobic assembly","volume":"437","author":"Chandler","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2006.12.004_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-2836(02)01408-0","article-title":"Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions","volume":"326","author":"Hendlich","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.12.004_bib60","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1073\/pnas.79.16.4843","article-title":"Electronic distribution within protein phenylalanine aromatic rings are reflected by the three-dimensional oxygen atom environments","volume":"79","author":"Thomas","year":"1982","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2006.12.004_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-2836(02)00885-9","article-title":"GXXXG and GXXXA motifs stabilize FAD and NAD(P)-binding Rossman folds through C\u03b1-H\u00b7\u00b7\u00b7 O hydrogen bonds and van der Waals interactions","volume":"323","author":"Kleiger","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.12.004_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/prot.10567","article-title":"N-H\u2026O, O-H\u2026O, and C-H\u2026O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition","volume":"54","author":"Sarkhel","year":"2004","journal-title":"Proteins: Struct. Funct. Genet."},{"key":"10.1016\/j.jmb.2006.12.004_bib63","series-title":"Protein-Ligand interactions: From Molecular Recognition to Drug Design","first-page":"137","article-title":"Hydrogen bonds in Protein-ligand complexes","author":"Williams","year":"2003"},{"key":"10.1016\/j.jmb.2006.12.004_bib64","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/jm0004594","article-title":"Toward the design of chemical libraries for mass screening biased against mutagenic compounds","volume":"44","author":"Llorens","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2006.12.004_bib66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography and NMR system: a new software suite for macromolecular structure determination","volume":"54","author":"Brunger","year":"1998","journal-title":"Acta Crystallog. sect. D"},{"key":"10.1016\/j.jmb.2006.12.004_bib67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0076-6879(97)77018-6","article-title":"SHELXL: high-resolution refinement","volume":"277","author":"Sheldrick","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2006.12.004_bib68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallog. sect. A"},{"key":"10.1016\/j.jmb.2006.12.004_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallog."},{"key":"10.1016\/j.jmb.2006.12.004_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W","article-title":"Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules","volume":"19","author":"Fraczkiewicz","year":"1998","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.jmb.2006.12.004_bib71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0022-2836(73)90011-9","article-title":"Environment and exposure to solvent of protein atoms. Lysozyme and insulin","volume":"79","author":"Shrake","year":"1973","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2006.12.004_bib72","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S1359-6446(05)03610-X","article-title":"Measurements of binding thermodynamics in drug discovery","volume":"10","author":"Holdgate","year":"2005","journal-title":"Drug Discov. Today"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283606016639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283606016639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T13:31:13Z","timestamp":1736688673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283606016639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0022283606016639"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2006.12.004","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}